- Home
- WAI vs KTTA Comparison
WAI vs KTTA Comparison
Compare WAI & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- KTTA
- Stock Information
- Founded
- WAI 2018
- KTTA 2020
- Country
- WAI China
- KTTA United States
- Employees
- WAI N/A
- KTTA N/A
- Industry
- WAI
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- WAI
- KTTA Health Care
- Exchange
- WAI NYSE
- KTTA Nasdaq
- Market Cap
- WAI 5.5M
- KTTA 5.1M
- IPO Year
- WAI 2023
- KTTA 2021
- Fundamental
- Price
- WAI $0.48
- KTTA $0.73
- Analyst Decision
- WAI
- KTTA
- Analyst Count
- WAI 0
- KTTA 0
- Target Price
- WAI N/A
- KTTA N/A
- AVG Volume (30 Days)
- WAI 5.9M
- KTTA 113.1K
- Earning Date
- WAI 08-24-2025
- KTTA 08-12-2025
- Dividend Yield
- WAI N/A
- KTTA N/A
- EPS Growth
- WAI N/A
- KTTA N/A
- EPS
- WAI N/A
- KTTA N/A
- Revenue
- WAI $3,750,352.00
- KTTA N/A
- Revenue This Year
- WAI N/A
- KTTA N/A
- Revenue Next Year
- WAI N/A
- KTTA N/A
- P/E Ratio
- WAI N/A
- KTTA N/A
- Revenue Growth
- WAI N/A
- KTTA N/A
- 52 Week Low
- WAI $0.41
- KTTA $0.65
- 52 Week High
- WAI $20.00
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- KTTA 44.60
- Support Level
- WAI N/A
- KTTA $0.68
- Resistance Level
- WAI N/A
- KTTA $0.75
- Average True Range (ATR)
- WAI 0.00
- KTTA 0.03
- MACD
- WAI 0.00
- KTTA 0.01
- Stochastic Oscillator
- WAI 0.00
- KTTA 78.35
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).